| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 290 | 44.559 | 53.832 | 97.321 | 236.452 | 230.208 | 239.932 | 505.653 |
| Total Income - EUR | - | - | 290 | 72.711 | 65.782 | 98.324 | 236.452 | 230.208 | 260.149 | 583.252 |
| Total Expenses - EUR | - | - | 8.385 | 72.105 | 64.094 | 86.558 | 219.510 | 227.671 | 246.086 | 532.003 |
| Gross Profit/Loss - EUR | - | - | -8.095 | 606 | 1.688 | 11.766 | 16.942 | 2.538 | 14.062 | 51.248 |
| Net Profit/Loss - EUR | - | - | -8.104 | 161 | 1.150 | 10.793 | 14.862 | 235 | 11.461 | 42.529 |
| Employees | - | - | 0 | 2 | 2 | 1 | 3 | 3 | 3 | 5 |
Check the financial reports for the company - Avisbio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 2.204 | 1.632 | 1.082 | 550 | 42 | 154.906 | 189.500 |
| Current Assets | - | - | 8.393 | 26.222 | 20.209 | 26.558 | 187.664 | 200.662 | 65.103 | 146.601 |
| Inventories | - | - | 8.286 | 10.659 | 0 | 3.778 | 7.782 | 13.853 | 17.341 | 64.194 |
| Receivables | - | - | 22 | 10.623 | 16.334 | 18.868 | 176.046 | 182.022 | 39.584 | 74.330 |
| Cash | - | - | 85 | 4.940 | 3.875 | 3.912 | 3.836 | 4.787 | 8.178 | 8.077 |
| Shareholders Funds | - | - | -5.915 | -5.645 | -4.387 | 6.490 | 21.207 | 21.508 | 22.493 | 64.897 |
| Social Capital | - | - | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | 14.308 | 37.939 | 35.288 | 30.040 | 175.698 | 189.639 | 197.516 | 271.204 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "147 - 147" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Avisbio Srl